The relationship between polymorphism of IGF2BP2 gene rs4402960 and risk of pan-cancer: a meta-analysis and a bioinformatics analysis

References

• Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68, 394–424. DOI: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Koh, G.; Degasperi, A.; Zou, X.; Momen, S.; Nik-Zainal, S. Mutational Signatures: Emerging Concepts, Caveats and Clinical Applications. Nat. Rev. Cancer 2021, 21, 619–637. DOI: 10.1038/s41568-021-00377-7.
   PubMed Web of Science ®Google Scholar
• Akimoto, N.; Ugai, T.; Zhong, R.; Hamada, T.; Fujiyoshi, K.; Giannakis, M.; Wu, K.; Cao, Y.; Ng, K.; Ogino, S.; et al. Rising Incidence of Early-Onset Colorectal Cancer - a Call to Action. Nat. Rev. Clin. Oncol. 2021, 18, 230–243. DOI: 10.1038/s41571-020-00445-1.
   PubMed Web of Science ®Google Scholar
• Chou, C.-H.; Chang, C.-Y.; Lu, H.-J.; Hsin, M.-C.; Chen, M.-K.; Huang, H.-C.; Yeh, C.-M.; Lin, C.-W.; Yang, S.-F. IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer. Int. J. Mol. Sci. 2020, 21, 5662. DOI: 10.3390/ijms21165662.
   PubMed Web of Science ®Google Scholar
• Chen, S.; Qiu, H.; Liu, C.; Wang, Y.; Tang, W.; Kang, M. Relationship between IGF2BP2 and IGFBP3 Polymorphisms and Susceptibility to Non-Small-Cell Lung Cancer: A Case-Control Study in Eastern Chinese Han Population. Cancer Manag. Res. 2018, 10, 2965–2975. DOI: 10.2147/cmar.S169222.
   PubMed Web of Science ®Google Scholar
• Tang, W.; Chen, S.; Liu, J.; Liu, C.; Wang, Y.; Kang, M. Investigation of IGF1, IGF2BP2, and IGFBP3 Variants with Lymph Node Status and Esophagogastric Junction Adenocarcinoma Risk. J. Cell Biochem. 2019, 120, 5510–5518. DOI: 10.1002/jcb.27834.
   PubMed Web of Science ®Google Scholar
• Liu, X.; Chen, Z.; Zhao, X.; Huang, M.; Wang, C.; Peng, W.; Yin, J.; Li, J.; He, G.; Li, X.; et al. Effects of IGF2BP2, KCNQ1 and GCKR Polymorphisms on Clinical Outcome in Metastatic Gastric Cancer Treated with EOF Regimen. Pharmacogenomics 2015, 16, 959–970. DOI: 10.2217/pgs.15.49.
   PubMed Web of Science ®Google Scholar
• Cao, J.; Mu, Q.; Huang, H. The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells. Stem Cells Int. 2018, 2018, 4217215–4217259. DOI: 10.1155/2018/4217259.
   Web of Science ®Google Scholar
• Hu, X.; Peng, W.-X.; Zhou, H.; Jiang, J.; Zhou, X.; Huang, D.; Mo, Y.-Y.; Yang, L. IGF2BP2 Regulates DANCR by Serving as an N6-Methyladenosine Reader. Cell Death Differ. 2020, 27, 1782–1794. DOI: 10.1038/s41418-019-0461-z.
   PubMed Web of Science ®Google Scholar
• Nfor, O. N.; Ndzinisa, N. B.; Tsai, M. H.; Hsiao, C. H.; Liaw, Y. P. Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes. Diabetes Metab. Syndr. Obes. 2020, 13, 5097–5102. DOI: 10.2147/dmso.S289642.
   PubMed Web of Science ®Google Scholar
• Jia, H.; Yu, L.; Jiang, Z.; Ji, Q. Association between IGF2BP2 rs4402960 Polymorphism and Risk of Type 2 Diabetes Mellitus: A Meta-Analysis. Arch. Med. Res. 2011, 42, 361–367. DOI: 10.1016/j.arcmed.2011.08.001.
   PubMed Web of Science ®Google Scholar
• Benrahma, H.; Charoute, H.; Lasram, K.; Boulouiz, R.; Atig, R. K.-B.; Fakiri, M.; Rouba, H.; Abdelhak, S.; Barakat, A. Association Analysis of IGF2BP2, KCNJ11, and CDKAL1 Polymorphisms with Type 2 Diabetes Mellitus in a Moroccan Population: A Case-Control Study and Meta-Analysis. Biochem. Genet. 2014, 52, 430–442. DOI: 10.1007/s10528-014-9658-5.
   PubMed Web of Science ®Google Scholar
• Pu, J.; Wang, J.; Qin, Z.; Wang, A.; Zhang, Y.; Wu, X.; Wu, Y.; Li, W.; Xu, Z.; Lu, Y.; et al. IGF2BP2 Promotes Liver Cancer Growth through an m6A-FEN1-Dependent Mechanism. Front Oncol. 2020, 10, 578816. DOI: 10.3389/fonc.2020.578816.
   PubMed Web of Science ®Google Scholar
• Li, T.; Hu, P.-S.; Zuo, Z.; Lin, J.-F.; Li, X.; Wu, Q.-N.; Chen, Z.-H.; Zeng, Z.-L.; Wang, F.; Zheng, J.; et al. METTL3 Facilitates Tumor Progression via an m(6)A-IGF2BP2-Dependent Mechanism in Colorectal Carcinoma. Mol. Cancer 2019, 18, 112. DOI: 10.1186/s12943-019-1038-7.
   PubMed Web of Science ®Google Scholar
• Xu, X.; Yu, Y.; Zong, K.; Lv, P.; Gu, Y. Up-Regulation of IGF2BP2 by Multiple Mechanisms in Pancreatic Cancer Promotes Cancer Proliferation by Activating the PI3K/Akt Signaling Pathway. J. Exp. Clin. Cancer Res. 2019, 38, 497. DOI: 10.1186/s13046-019-1470-y.
   PubMed Web of Science ®Google Scholar
• Sainz, J.; Rudolph, A.; Hoffmeister, M.; Frank, B.; Brenner, H.; Chang-Claude, J.; Hemminki, K.; Försti, A. Effect of Type 2 Diabetes Predisposing Genetic Variants on Colorectal Cancer Risk. J. Clin. Endocrinol. Metab. 2012, 97, E845–851. DOI: 10.1210/jc.2011-2565.
   PubMed Web of Science ®Google Scholar
• Qiu, H.; Wang, Y.; Kang, M.; Ding, H.; Liu, C.; Tang, W.; Xiao, Z.; Chen, Y. The Relationship between IGF2BP2 and PPARG Polymorphisms and Susceptibility to Esophageal Squamous-Cell Carcinomas in the Eastern Chinese Han Population. Onco. Target. Ther. 2017, 10, 5525–5532. DOI: 10.2147/ott.S145776.
   PubMed Web of Science ®Google Scholar
• Almawi, W. Y.; Zidi, S.; Sghaier, I.; El-Ghali, R. M.; Daldoul, A.; Midlenko, A. Novel Association of IGF2BP2 Gene Variants with Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer. Clin. Breast Cancer 2023, 23, 272–280. DOI: 10.1016/j.clbc.2022.12.017.
   PubMed Web of Science ®Google Scholar
• Liu, G.; Zhu, T.; Cui, Y.; Liu, J.; Liu, J.; Zhao, Q.; Zhang, K.; Zhao, R. Correlation between IGF2BP2 Gene Polymorphism and the Risk of Breast Cancer in Chinese Han Women. Biomed. Pharmacother. 2015, 69, 297–300. DOI: 10.1016/j.biopha.2014.12.017.
   PubMed Web of Science ®Google Scholar
• Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D. G, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann. Intern. Med. 2009, 151, 264–269, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• Zhou, T.; Cai, Z.; Ma, N.; Xie, W.; Gao, C.; Huang, M.; Bai, Y.; Ni, Y.; Tang, Y. A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma. Front Cell Dev. Biol. 2020, 8, 629. DOI: 10.3389/fcell.2020.00629.
   PubMed Web of Science ®Google Scholar
• Meng, J.; Fan, X.; Zhang, M.; Hao, Z.; Liang, C. Do Polymorphisms in Protein Kinase Catalytic Subunit Alpha-1 Gene Associated with Cancer Susceptibility? a Meta-Analysis and Systematic Review. BMC Med. Genet. 2018, 19, 189. DOI: 10.1186/s12881-018-0704-8.
   PubMed Web of Science ®Google Scholar
• Meng, J.; Li, W.; Zhang, M.; Hao, Z.; Fan, S.; Zhang, L.; Liang, C. An Update Meta-Analysis and Systematic Review of TAP Polymorphisms as Potential Biomarkers for Judging Cancer Risk. Pathol. Res. Pract. 2018, 214, 1556–1563. DOI: 10.1016/j.prp.2018.07.018.
   PubMed Web of Science ®Google Scholar
• Lowe, W. L.; Jr., Scholtens, D. M.; Sandler, V.; Hayes, M. G. Genetics of Gestational Diabetes Mellitus and Maternal Metabolism. Curr. Diab. Rep. 2016, 16, 15. DOI: 10.1007/s11892-015-0709-z.
   PubMed Web of Science ®Google Scholar
• Cao, J.; Yan, W.; Ma, X.; Huang, H.; Yan, H. Insulin-like Growth Factor 2 mRNA-Binding Protein 2-a Potential Link between Type 2 Diabetes Mellitus and Cancer. J. Clin. Endocrinol. Metab. 2021, 106, 2807–2818. DOI: 10.1210/clinem/dgab391.
   PubMed Web of Science ®Google Scholar
• Bi, Z.; Liu, Y.; Zhao, Y.; Yao, Y.; Wu, R.; Liu, Q.; Wang, Y.; Wang, X. A Dynamic Reversible RNA N(6) -Methyladenosine Modification: Current Status and Perspectives. J. Cell Physiol. 2019, 234, 7948–7956. DOI: 10.1002/jcp.28014.
   PubMed Web of Science ®Google Scholar
• Dai, N. The Diverse Functions of IMP2/IGF2BP2 in Metabolism. Trend. Endocrinol. Metab. 2020, 31, 670–679. DOI: 10.1016/j.tem.2020.05.007.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Chen, L.; Qiang, P. The Role of IGF2BP2, an m6A Reader Gene, in Human Metabolic Diseases and Cancers. Cancer Cell Int. 2021, 21, 99. DOI: 10.1186/s12935-021-01799-x.
   PubMed Web of Science ®Google Scholar
• Fan, S.; Meng, J.; Zhang, L.; Zhang, X.; Liang, C. CAV1 Polymorphisms rs1049334, rs1049337, rs7804372 Might Be the Potential Risk in Tumorigenicity of Urinary Cancer: A Systematic Review and Meta-Analysis. Pathol. Res. Pract. 2019, 215, 151–158. DOI: 10.1016/j.prp.2018.11.009.
   PubMed Web of Science ®Google Scholar
• Shao, W.; Zhao, H.; Zhang, S.; Ding, Q.; Guo, Y.; Hou, K.; Kan, Y.; Deng, F.; Xu, Q. A Pan-Cancer Landscape of IGF2BPs and Their Association with Prognosis, Stemness and Tumor Immune Microenvironment. Front Oncol. 2022, 12, 1049183. DOI: 10.3389/fonc.2022.1049183.
   PubMed Web of Science ®Google Scholar
• Cui, J.; Tian, J.; Wang, W.; He, T.; Li, X.; Gu, C.; Wang, L.; Wu, J.; Shang, A. IGF2BP2 Promotes the Progression of Colorectal Cancer through a Yap-Dependent Mechanism. Cancer Sci. 2021, 112, 4087–4099. DOI: 10.1111/cas.15083.
   PubMed Web of Science ®Google Scholar
• Li, J.; Gao, X.; Zhang, Z.; Lai, Y.; Lin, X.; Lin, B.; Ma, M.; Liang, X.; Li, X.; Lv, W.; et al. CircCD44 Plays Oncogenic Roles in Triple-Negative Breast Cancer by Modulating the miR-502-5p/KRAS and IGF2BP2/Myc Axes. Mol Cancer 2021, 20, 138. DOI: 10.1186/s12943-021-01444-1.
   PubMed Web of Science ®Google Scholar
• Latifkar, A.; Wang, F.; Mullmann, J. J.; Panizza, E.; Fernandez, I. R.; Ling, L.; Miller, A. D.; Fischbach, C.; Weiss, R. S.; Lin, H.; et al. IGF2BP2 Promotes Cancer Progression by Degrading the RNA Transcript Encoding a v-ATPase Subunit. Proc. Natl. Acad. Sci. U S A 2022, 119, e2200477119. DOI: 10.1073/pnas.2200477119.
   PubMed Web of Science ®Google Scholar
• Lang, C.; Yin, C.; Lin, K.; Li, Y.; Yang, Q.; Wu, Z.; Du, H.; Ren, D.; Dai, Y.; Peng, X.; et al. m(6) a Modification of lncRNA PCAT6 Promotes Bone Metastasis in Prostate Cancer through IGF2BP2-Mediated IGF1R mRNA Stabilization. Clin. Transl. Med. 2021, 11, e426. DOI: 10.1002/ctm2.426.
   PubMed Web of Science ®Google Scholar
• Liu, T.-Y.; Hu, C.-C.; Han, C.-Y.; Mao, S.-Y.; Zhang, W.-X.; Xu, Y.-M.; Sun, Y.-J.; Jiang, D.-B.; Zhang, X.-Y.; Zhang, J.-X.; et al. IGF2BP2 Promotes Colorectal Cancer Progression by Upregulating the Expression of TFRC and Enhancing Iron Metabolism. Biol. Direct. 2023, 18, 19. DOI: 10.1186/s13062-023-00373-x.
   PubMed Web of Science ®Google Scholar